το περιεχόμενο θα ανανεωθεί σύντομα.
Fellowship – in Breast Cancer and Gynecological Cancer Care
University Oncology Clinic, Papageorgiou Hospital,
Thessaloniki
Clinical Oncology Specialty Training:
Sarcoma and Lung Cancer Department
Institut Gustave Roussy, European Cancer Centre,
Département de Médecine Oncologique
Paris, France
Residency – in Medical Oncology ,
University Oncology Clinic, Papageorgiou Hospital,
Thessaloniki
Residency- in Internal Medicine , Hematology
2nd Oncology Department and Hematology Department
"Theagenio" Cancer Hospital,
Thessaloniki
Compulsorycountry service in the Health Center of Kithnos Island
HouseOfficer, Internal Medicine Department,
GeneralHospital of Syros Island
ClinicalFellow, Section of Nephrology and Hypertension,
1stDepartment of Medicine, "AHEPA" Hospital,
AristotleUniversity of Thessaloniki
Aristotle University of Thessaloniki, Faculty of Health Sciences,
Medical School, Ptychion Iatrikis
2010
Alexander Technological Educational Institute Of Thessaloniki,
Medical Laboratory Studies,
2004
· Επιπλέον εξειδίκευση
Preceptorships in Clinical and Translational Cancer Research
Master Classes on circulating tumor cells and mollecular biomarkers, Department of Medical Oncology , University Hospital of Heraklion, Crete
Statistical Principles in Clinical Trials, NHS Foundation
Biology of Cancer, Biomedical Research Foundation Academy of Athens (BRFAA)
Medical Oncology-Training sessions of the Hellenic Academy of Oncology
· Additional information
During my training I have been involved in the management ofoncological patients and particularly with admissions, patient’s assessment andeveryday medical care. I have gained broad experience in a variety of solidtumors and also participated in several Cancer MultiDisciplinary Team meetingsand journal clubs. I have also attended multiple conferences and congresses onClinical Oncology. During my training I was in closed collaboration with DrAxel Lecesne and Dr David Planchard, who encouraged me to get more clinicalexperience in Gustave Roussy Oncology Institute, international renown in theclinical and translational research of cancer.
RESEARCH / ΕΡΕΥΝΑ(Highlights/Σημαντικότερα ερευνητικά προγράμματα)
Sub-Investigator in 20190294 Study : A Non-interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Non-Small Cell Lung Cancer (NSCLC)
Currently recruiting subjects
Sub-Investigator in 20190009 Study : A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of previously treated Locally Advanced and unresectable or Metastatic NSCLC Subjects with Mutated KRAS p.G12C
Currently recruiting subjects
Sub-Investigator in 20180020 Study : A Multi-country Observational Serial Chart Review Study of the trastuzumab biosimilar ABP 980
Study enrollment hasclosed on 13Oct2020
Sub-Investigator in 109493 Study MAGRIT 109493 : A Double-blind, randomized, placebo-controlled Ph. III study to assess the efficacy of rec MAGE-A3 +AS15 Antigen -specific Cancer Immunotherapy as adjuvant therapy in patients with respectable MAGE-A3 positive NSCLC.
Study has closed on 2014
Publications/ Δημοσιεύσεις (Ιnternational Book Publication)
International Manual of Oncology Practice (iMOP)
- Principles of Medical Oncology - Metabolic Disturbances as Paraneoplastic Syndromes Eleni I. Zairi, Pages 1009-1021
- SPRINGER publications ·
2015
· Κλινική Ογκολογία και Θεραπευτική:
Καρκίνος Μαστού
Γυναικολογικός Καρκίνος
Καρκίνος Πνεύμονα και Όγκοι Μεσοθωρακίου
Σάρκωμα και Γαστρεντερικοί Στρωματικοί Όγκοι
· Ανθρωπομετρικά χαρακτηριστικά και προληπτική ιατρική
· Υποστηρικτική και Παρηγορητική Φροντίδα
· Παρανεοπλασματικά Σύνδρομα